Knowledge and perception of biosimilars in ambulatory care: a survey among Belgian community pharmacists and physicians
Background With the approval of biosimilars for subcutaneously administered products, such as adalimumab, etanercept and insulin, biosimilars become increasingly available in ambulatory care. Little is known about the knowledge and attitudes of healthcare providers who are in charge of dispensing an...
Furkejuvvon:
| Váldodahkkit: | , , , , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
Taylor & Francis Group
2021-12-01
|
| Ráidu: | Journal of Pharmaceutical Policy and Practice |
| Fáttát: | |
| Liŋkkat: | http://dx.doi.org/10.1186/s40545-021-00330-x |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|